Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China flag China · Delayed Price · Currency is CNY
17.40
-0.64 (-3.55%)
May 12, 2026, 3:12 PM CST

SHE:300497 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
471.51482.98695.35729.37978.031,272
Trading Asset Securities
0.820.952.192.1949.74150.76
Cash & Short-Term Investments
472.32483.93697.54731.561,0281,423
Cash Growth
-26.51%-30.62%-4.65%-28.82%-27.79%-15.88%
Accounts Receivable
619.32533.29498.16572.92552.49376.21
Other Receivables
30.6425.4553.85128.3178.2180.01
Receivables
649.96558.74552.01701.23630.71456.22
Inventory
381.66379.93421.05434.68553.69416.15
Other Current Assets
45.2638.7410.429.9717.1115.97
Total Current Assets
1,5491,4611,6811,8772,2292,312
Property, Plant & Equipment
2,2762,2902,2672,3312,2011,857
Long-Term Investments
271.31271.31255.9271.27271.42133.02
Goodwill
----1.152.22
Other Intangible Assets
285.64287.85235241.07249.71256.32
Long-Term Deferred Tax Assets
35.0434.837.2629.3728.4927.54
Other Long-Term Assets
62.5759.6960.9569.1378.7990.82
Total Assets
4,4794,4054,5374,8195,0604,678
Accounts Payable
322.47348.04603.37581.93656.67517.05
Accrued Expenses
13.2219.0644.0544.5242.451.97
Short-Term Debt
731.5571.5556.4549.83366.74615.18
Current Portion of Long-Term Debt
69.34270.02311.7878.787.9633.5
Current Income Taxes Payable
13.877.110.050.828.7113.89
Current Unearned Revenue
3.752.032.723.41.421.82
Other Current Liabilities
115.6651.525.4626.32174.96126.56
Total Current Liabilities
1,2701,2691,5441,2861,2591,360
Long-Term Debt
815.44809.46736.48998.261,043353
Long-Term Unearned Revenue
123.21123.9777.6762.3962.0350.3
Long-Term Deferred Tax Liabilities
1.841.861.962.056.273.92
Total Liabilities
2,2102,2052,3602,3482,3701,767
Common Stock
538.65538.65550550550550
Additional Paid-In Capital
1,2491,2471,3811,4141,4081,406
Retained Earnings
414.95353.75408.78680.88881.681,023
Treasury Stock
---174.86-174.86-174.86-105.11
Comprehensive Income & Other
44.5944.3315.4514.316.896.08
Total Common Equity
2,2472,1842,1802,4852,6812,880
Minority Interest
22.2316.38-3.54-14.068.431.1
Shareholders' Equity
2,2692,2002,1772,4712,6902,911
Total Liabilities & Equity
4,4794,4054,5374,8195,0604,678
Total Debt
1,6161,6511,6051,6271,4181,002
Net Cash (Debt)
-1,144-1,167-907.13-895.31-389.97421.54
Net Cash Growth
------66.26%
Net Cash Per Share
-2.10-2.12-1.70-1.65-0.720.78
Filing Date Shares Outstanding
536.8538.65538.65538.65538.65538.65
Total Common Shares Outstanding
536.8538.65538.65538.65538.65543.13
Working Capital
279.4192.09137.2591.84970.42951.59
Book Value Per Share
4.194.054.054.614.985.30
Tangible Book Value
1,9611,8961,9452,2442,4302,622
Tangible Book Value Per Share
3.653.523.614.174.514.83
Buildings
--936.67836.72712.09471.86
Machinery
--1,6411,4231,232851.39
Construction In Progress
--457.86695.78736.4922.19
Source: S&P Global Market Intelligence. Standard template. Financial Sources.